Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy

European Journal of Neuroscience

Volumn 24, Issue 4, 2006, Pages 1085-1090

  Cente, Martin ^a,b   Filipcik, Peter ^a,b   Pevalova, Miroslava ^a,b   Novak, Michal ^a  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience Forschungs und Entwicklungs GmbH   (Austria)

Author keywords

Alzheimer's disease; Neurodegeneration; Oxidative stress; Transgenic rat

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUCOSE OXIDASE; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL DEATH; CELL FUNCTION; CELL STIMULATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG TARGETING; EMBRYO; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; STATISTICAL ANALYSIS; TAUOPATHY; TRANSGENE; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLUCOSE OXIDASE; HUMANS; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; PROTEIN ISOFORMS; RATS; REACTIVE OXYGEN SPECIES; TAU PROTEINS; TAUOPATHIES;

EID: 33747606218     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04986.x     Document Type: Article

References (38)

1. Aliev, G., Smith, M.A., de la Torre, J.C. & Perry, G. (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion, 4, 649-663.
2. Bondareff, W., Wischik, C.M., Novak, M., Amos, W.B., Klug, A. & Roth, M. (1990) Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am. J. Pathol., 137, 711-723.
3. Braak, H. & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82, 239-259.
4. Callahan, L.M. & Coleman, P.D. (1995) Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging, 16, 311-314.
5. Chee, F.C., Mudher, A., Cuttle, M.F., Newman, T.A., MacKay, D., Lovestone, S. & Shepherd, D. (2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol. Dis., 20, 918-928.
6. Chow, N., Cox, C., Callahan, L.M., Weimer, J.M., Guo, L. & Coleman, P.D. (1998) Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 95, 9620-9625.
7. Csokova, N., Skrabana, R., Liebig, H.D., Mederlyova, A., Kontsek, P. & Novak, M. (2004) Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expr. Purif., 35, 366-372.
8. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. & Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell. Biol., 143, 777-794.
9. Eide, L. & McMurray, C.T. (2005) Culture of adult mouse neurons. Biotechniques, 38, 99-104.
10. Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., van Swieten, J.C., Hofman, A., Witteman, J.C. & Breteler, M.M. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA, 287, 3223-3229.
11. Garcia-Sierra, F., Ghoshal, N., Quinn, B., Berry, R.W. & Binder, L.I. (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J. Alzheimers Dis., 5, 65-77.
12. Gilgun-Sherki, Y., Melamed, E. & Offen, D. (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol., 251, 261-268.
13. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. & Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA, 83, 4913-4917.
14. Hatanpaa, K., Brady, D.R., Stoll, J., Rapoport, S.I. & Chandrasekaran, K. (1996) Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., 40, 411-420.
15. Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C.A., Weintraub, S.T., Bennett, D.A., Cryns, V.L., Berry, R.W. & Binder, L.I. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci., 24, 7895-7902.
16. Iqbal, K., Alonso Adel, C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H. & Grundke-Iqbal, I. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta, 1739, 198-210.
17. Kril, J.J., Patel, S., Harding, A.J. & Halliday, G.M. (2002) Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol., 103, 370-376.
18. Laurin, D., Masaki, K.H., Foley, D.J., White, L.R. & Launer, I.J. (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am. J. Epidemiol., 159, 959-967.
19. Luchsinger, J.A., Tang, M.X., Shea, S. & Mayeux, R. (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch. Neurol., 60, 203-208.
20. Madamanchi, N.R., Vendrov, A. & Runge, M.S. (2005) Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol., 25, 29-38.
21. Matteucci, E., Mavaldi, G., Fagnani, F., Evangelista, I. & Giampietro, O. (2004) Redox status and immune function in type I diabetes families. Clin. Exp. Immunol., 136, 549-554.
22. Moreira, P.I., Smith, M.A., Zhu, X., Honda, K., Lee, H.G., Aliev, G. & Perry, G. (2005) Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? Drug News Perspect., 18, 13-19.
23. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Aggarwal, N., Wilson, R.S. & Scherr, P.A. (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA, 287, 3230-3237.
24. Morsch, R., Simon, W. & Coleman, P.D. (1999) Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol., 58, 188-197.
25. Novak, M. (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol., 38, 173-189.
26. Novak, M., Kabat, J. & Wischik, C.M. (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J., 12, 365-370.
27. Novak, M., Ugolini, G., Fasulo, L., Visintin, M., Ovecka, M. & Cattaneo, A. (1999) Truncation of tau and neurodegeneration. In Iqbal, K., Swaab, D.F., Winblad, B. & Wisniewski, H.M. (eds), Alzheimer's Disease and Related Disorders. Etiology, Pathologenesis and Therapeutics. John Wiley & Sons Ltd, New York, pp. 281-291.
28. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E.K., Jones, P.K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C.S., Petersen, R.B. & Smith, M.A. (2002) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol., 60, 759-767.
29. Perry, G., Nunomura, A., Hirai, K., Zhu, X., Perez, M., Avila, J., Castellani, R.J., Atwood, C.S., Aliev, G., Sayre, L.M., Takeda, A. & Smith, M.A. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med., 33, 1475-1479.
30. Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C.H. & Thal, L.J. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med., 352, 2379-2388.
31. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science, 298, 789-791.
32. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell. Biol., 156, 1051-1063.
33. Toyokuni, S. (1998) Oxidative stress and cancer: The role of redox regulation. Biotherapy, 11, 147-154.
34. Wang, J.Z., Grundke-Iqbal, I. & Iqbal, K. (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nat. Med., 2, 871-875.
35. Wang, H. & Joseph, J.A. (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med., 27, 612-616.
36. Watanabe, A., Hong, W.K., Dohmae, N., Takio, K., Morishima-Kawashima, M. & Ihara, Y. (2004) Molecular aging of tau: disulfide-independent aggregation and non-enzymatic degradation in vitro and in vivo. J. Neurochem., 90, 1302-1311.
37. Yan, S.D., Chen, X., Schmidt, A.M., Brett, J., Godman, G., Zou, Y.S., Scott, C.W., Caputo, C., Frappier, T., Smith, M.A., Yen, S.H. & Stern, D. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl Acad. Sci. USA, 91, 7787-7791.
38. Zilka, N., Filipcik, P., Koson, P., Vechterova, L., Skrabana, R., Zilkova, M., Rolkova, G., Kontsekova, E. & Novak, M. (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett., 580, 3582-3588.